PacWest Financial Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$16.2M Buy
22,747
+1,079
+5% +$84.8K 0.96% 46
2016
Q3
$1.87M Sell
21,668
-305
-1% -$26.6K 1.15% 39
2016
Q2
$1.91M Sell
21,973
-555
-2% -$44.9K 1.19% 39
2016
Q1
$1.69M Buy
22,528
+8,533
+61% +$643K 1.09% 44
2015
Q4
$1.08M Buy
13,995
+1,300
+10% +$97.9K 0.72% 61
2015
Q3
$850K Buy
12,695
+3,290
+35% +$242K 0.63% 64
2015
Q2
$733K Hold
9,405
0.52% 69
2015
Q1
$733K Buy
9,405
+555
+6% +$42.1K 0.52% 68
2014
Q4
$639K Buy
8,850
+2,709
+44% +$188K 0.45% 73
2014
Q3
$380K Buy
6,141
+1,170
+24% +$74.4K 0.28% 75
2014
Q2
$317K Sell
4,971
-253
-5% -$15.4K 0.24% 76
2014
Q1
$321K Sell
5,224
-1,325
-20% -$77.2K 0.25% 77
2013
Q4
$376 Buy
6,549
+158
+2% +$8.96K 0.11% 80
2013
Q3
$340K Sell
6,391
-875
-12% -$47.1K 0.29% 79
2013
Q2
$374K Buy
+7,266
New +$359K 0.36% 73

Other funds holding MDT

PacWest Financial Management's MDT Position: Q4 2016 in Review

PacWest Financial Management increased its Medtronic (MDT) stake by 5% in Q4 2016, buying an estimated $84.8K and bringing the position to 22,747 shares worth $16.2M. The position accounts for 0.96% of the portfolio, ranked #46.

PacWest Financial Management first reported a position in MDT in Q2 2013 and has held it in 15 quarters since. 1,269 funds tracked by Wall St. Rank hold MDT as of Q4 2016.

  • PacWest Financial Management held 22,747 shares of Medtronic worth $16.2M as of Q4 2016.
  • PacWest Financial Management bought 1,079 Medtronic shares in Q4 2016, an estimated $84.8K.
  • Medtronic made up 0.96% of PacWest Financial Management's portfolio in Q4 2016, its #46 holding.
  • PacWest Financial Management first reported a position in Medtronic in Q2 2013 and has held it in 15 quarters since.
  • 1,269 funds tracked by Wall St. Rank held Medtronic as of Q4 2016.

Based on PacWest Financial Management's 13F filing for Q4 2016, filed 10 Jan 2017.